Your body is 3D, why is your cell culture not? Christian Oberdanner, PhD, Application Specialist Sales & Marketing, Tecan Austria GmbH
Circulating Tumor Antigens and their Autoantibody Reactivity as Cancer Markers Samir Hanash, Program Head, Fred Hutchinson Cancer Research Center, speaking at CellTech 2013.
A lesson for cell-signaling studies using advanced detection techniques Thomas Hengstl MSc, Application Specialist Marketing, Tecan Austria
Fluid Phase of Solid Tumors: Using CTCs as a Real Time Fluid Biopsy Anand Kolatkar, Researcher, Scripps Research Institute, speaking at CellTech 2013.
Helping you to shape in vitro models with cell-based assays Christian Oberdanner, Ph.D. Marketing Application Specialist Detection for Tecan Austria
The Isolation and Characterization of Brain Metastasis – Competent Breast Cancer CTCs Dario Marchetti, Professor/Director, Baylor College of Medicine, speaking at CellTech 2013.
Cationic Nanoparticles for Cancer Chemotherapy Erem Bilensoy, Associate Professor, Hacettepe University Faculty of Pharmacy, speaking at Nanomedicine Europe 2013.
Characterisation of an Automated Micro Bioreactor With CHO Cultures: Process Control, Clone Ranking, Process Optimisation and DoE Barney Zoro, TAP Biosystems, speaking at Stem Cells & Bioprocessing Europe 2012.
3D-Organotypic Cultures and Future Perspectives of Such Techniques in Predictive Toxicology Fozia Noor, Saarland University, speaking at Stem Cells & Bioprocessing Europe 2012.